Literature DB >> 19968960

Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.

Eun Kyung Lee1, Woo-Kwang Jeon, Min Young Chae, Hye-Young Hong, Youn Sook Lee, Jun Hwan Kim, Jae Young Kwon, Byung-Chul Kim, Seok Hee Park.   

Abstract

Transforming growth factor-beta (TGF-beta) is a cytokine important in inducing epithelial-mesenchymal transition (EMT), a crucial morphological event in a wide range of physiological and pathological cellular processes. In this study, we demonstrate that TGF-beta1 induces the EMT phenotype through decreasing the expression of the glutaredoxin 1 (Grx1) gene, an anti-oxidant enzyme, in H-Ras transformed EpH4 mammary epithelial cells (EpRas), but not in the parental EpH4 cells. TGF-beta1-induced reduction of Grx1 expression caused an increase of intracellular reactive oxygen species (ROS) in EpRas cells, and pre-treatment of the ROS scavenger N-acetylcysteine (NAC) inhibited TGF-beta1-induced EMT. Grx1-overexpressing EpRas cells showed a reduction in intracellular ROS generation and suppressed the expression of mesenchymal markers upon treatment of TGF-beta1. In addition, MEK/MAP kinase and phosphatidylinositol-3 kinase (PI3K) signaling were found to mediate the decrease in Grx1 expression upon TGF-beta1 treatment, depending on the presence of Ras protein. Thus our findings strongly suggest that TGF-beta1 promotes EMT by increasing intracellular ROS levels via down-regulation of the Grx1 gene in EpRas cells. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968960     DOI: 10.1016/j.bbrc.2009.12.009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.

Authors:  Yu Liu; Fei-Ya Du; Wei Chen; Pei-Fen Fu; Min-Ya Yao; Shu-Sen Zheng
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

2.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

3.  Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.

Authors:  Hongqiao Zhang; Honglei Liu; Zea Borok; Kelvin J A Davies; Fulvio Ursini; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

4.  Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition.

Authors:  Adam F Prasanphanich; C Andrew Arencibia; Melissa L Kemp
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

Review 5.  Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression.

Authors:  Jelena Krstić; Drenka Trivanović; Slavko Mojsilović; Juan F Santibanez
Journal:  Oxid Med Cell Longev       Date:  2015-05-20       Impact factor: 6.543

6.  Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.

Authors:  Suhong Yu; Cuicui Yan; Xingtian Yang; Sudang He; Jian Liu; Chongtao Qin; Chuanzhong Huang; Yusheng Lu; Zhongping Tian; Lee Jia
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

Review 7.  Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis.

Authors:  Rui-Ming Liu; Leena P Desai
Journal:  Redox Biol       Date:  2015-10-10       Impact factor: 11.799

8.  Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells.

Authors:  Yunshan Wang; Xiaoyan Liu; Hui Zheng; Qin Wang; Li An; Guangwei Wei
Journal:  Int J Mol Med       Date:  2017-09-01       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.